Drug Rehab Centers | How to Find the Right Drug Rehab Centers


 

Drug Rehab Centers | How To Find The Right Drug Rehab Centers – Finding the right drug rehab centers is not easy unless you know the secret. Not all drug treatment programs are the same and your success depends on finding the one that fits you best. In this video Louise tells her story and how she was able to quickly and easily connect with the drug rehab center that was the best fit for her. 24 hour Helpline at (877) 584-6395 OffThePharm.com

 

Top Health-Care Stocks for 2013

Filed under: drug rehab treatment programs

There are a variety of advancements underway in the treatment of cancer. Infinity Pharmaceuticals (INFI) is our leading pick for 2013. It's developing a cancer drug known as a PI3K inhibitor and should be a big play at ASCO, or the American Society of …
Read more on Barron’s

 

Master switch discovery could provide road map for treatment of arthritis and

Filed under: drug rehab treatment programs

Scientists trying to create drugs to treat chronic inflammation in diseases like arthritis now have a new culprit known MMP2. New University of British Columbia research shows that this enzyme works as a master switch to activate inflammatory diseases.
Read more on University of British Columbia

 

Patients must be involved in decisions to change their medication

Filed under: drug rehab treatment programs

The letter went on to say that her GP would switch her to two separate prescriptions equivalent to her current treatment, that her repeat prescription had been changed accordingly on the practice computer, but could she use up her current supply before …
Read more on The Guardian

 

Oncologists warn over English cancer drug funding

Filed under: drug rehab treatment programs

Since the CDF was launched in April 2011, over 21,000 patients in England have benefitted from treatments they would otherwise have been denied, and oncologists have gained access to 35 additional drugs or indications as a direct result of the Fund, …
Read more on PharmaTimes